Top of page
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation

Help us improve our content by rating this page.

Page rating system

Please leave a comment about your rating so we can better understand how we might improve the page.

You are here: Main Content

Professor Mel Ziman

Professor

Contact Information Telephone: +61 8 6304 3640, Mobile: 0419 929 851, Email: m.ziman@ecu.edu.au, Campus: Joondalup, Room: JO17.303
Staff Member Details
Telephone: +61 8 6304 3640
Mobile: 0419 929 851
Facsimile: +61 8 6304 2626
Email: m.ziman@ecu.edu.au
Campus: Joondalup  
Room: JO17.303  

 

Mel is a Professor in the School of Medical and Health Sciences, her areas of expertise include Melanoma and Huntington's disease. Mel is head of the ECU Melanoma Research Group.

Current Teaching

  • BSc Medical Science Honour Degree Coordination
  • Postgraduate Supervision

Background

  • 2013-present: Professor, School of Medical and Health Sciences, ECU
  • 2011-2013: Associate Professor, School of Medical Sciences, ECU
  • 2005-2010: Associate Professor, School of Exercise, Biomedical and Health Science, ECU
  • 2003-2005: Senior Lecturer, School of Exercise, Biomedical and Health Science, ECU
  • 2001-2003: Lecturer, School of Exercise, Biomedical and Health Science, ECU
  • 1996-2001: Senior Research Fellowship, School of Pathology and Laboratory Medicine, UWA

Professional Associations

  • Society for Melanoma Research, USA
  • ANZMTG
  • Australian Neuroscience Society,
  • Human Genetics Society of Australia,
  • Australian Society for Medical Research
  • Australian and New Zealand Society of Development and Cell Biology
  • Combined Biological Society
  • International Society of Differentiation (ISD)

Awards and Recognition

University and National Teaching Awards

  • 2012:UniJobs Lecturer of the Year Award for the Top 10 Lecturers at ECU in 2011
  • 2012:ECU award for Excellence in Postgraduate Supervision
  • 2011:VC Excellence Award for Engagement in Research
  • 2010:  VC Citation for excellence in development of a Teaching and Research Nexus
  • 2010: Citation for Outstanding Contribution to Student Learning – Australian Learning and Teaching
  • 2008: VC Citation for excellence in development of a Teaching and Research Nexus
  • 2008: Citation for Outstanding Contribution to Student Learning – Australian Learning and Teaching Council (Carrick)
  • 2008: ECU Certificate of excellence in Learning and Teaching – UTEI over 85
  • 2005: ECU award for Excellence in Postgraduate Supervision

Other

  • 2010 - 2016: NHMRC grant review panel member
  • 2009-2015: National OLT grant review panel member
  • 2015:   WAHTN Committee Member
  • 2014:Parliamentary Standing Committee on Health - Skin cancer in Australia
  • 2013:ASPIRE Professional Development Award, Perth Convention Bureau
  • 2012-  NHMRC Research Translation Faculty Member

Research Areas and Interests

  • The role of developmental genes in the proliferation, differentiation and migration of cells in the embryo and in disease processes such as cancer including Cutaneous Malignant Melanoma and neurodegenerative diseases including Huntington’s disease.
  • Characterisation of circulating cells in Melanoma
  • Multidisciplinary therapy and neurogenesis in Huntington’s disease.

Qualifications

  • Bachelor of Science Honours, South Africa.
  • Degree of Doctor of Philosophy, South Africa, 1983.

Research

Recent Research Grants

  • Enabling Advanced Single Cell Cancer Genomics in Western Australia,  Cancer Research Trust,  The Grant,  2017 - 2022,  $305,925.
  • The development and evaluation of a novel multidisciplinary therapy coaching program for people with mild-to-moderate Huntington’s disease. ,  Perpetual Ltd,  IMPACT Philanthropy Application Program,  2018 - 2021,  $445,021.
  • Liquid biopsy for personalised monitoring of melanoma patients ,  National Health and Medical Research Council,  Development Grants,  2017 - 2020,  $950,389.
  • Early Detection of Cancer Spread and Treatment of Ocular Melanoma ,  Cancer Council of WA Inc,  PhD Top Up Scholarship,  2018 - 2020,  $30,000.
  • Single Cell Whole Transcriptome Sequencing of Melanoma Circulating Tumour Cells (CTCs): Unveiling Cell Diversity,  Tour de Cure,  Pioneering Cancer Research Grant,  2018 - 2019,  $120,000.
  • A liquid biopsy to assist with staging of melanoma patients,  Perpetual Ltd,  IMPACT Philanthropy Application Program,  2017 - 2019,  $210,050.
  • Predictive significance of circulating tumour cells (CTCs), circulating tumour DNA (ctDNA) and serum vascular endothelial growth factor (VEGF) in advanced melanoma patients treated with pembrolizumab,  Merck Sharp and Dohme (Australia) Pty Ltd,  Grant,  2016 - 2019,  $73,300.
  • Development of a Multiplex Test for the Early Diagnosis of Melanoma,  Tour de Cure,  Senior Research Grant,  2019,  $280,000.
  • The effect of cognitive and exercise training on Brain Atrophy and Cognitive Decline in Breast Cancer Patients Treated with Adjuvant Chemotherapy Agents,  Cancer Council of WA Inc,  Collaborative Cancer Grant Scheme,  2018 - 2019,  $49,966.
  • Genetic Analysis of Blood Markers for Prognosis in Patients with Uveal Melanoma,  University of Western Australia,  Raine Foundation Grant,  2016 - 2018,  $100,000.
  • Medical and Health Research Infrastructure Fund 2016 (Round 20),  Department of Health WA,  Medical and Health Research Infrastructure,  2017 - 2018,  $13,910.
  • A Blood Based ‘Liquid Biopsy’ to Improve Healthcare for Metastatic Melanoma Patients,  Department of Health WA,  SHRAC Research Translation Projects,  2016 - 2018,  $4,075,030.
  • Blood Based Biomarkers Predictive of Treatment Response in Melanoma,  Cancer Council of WA Inc,  Grant,  2016 - 2018,  $246,822.
  • Circulating Tumour DNA to Predict and Monitor Treatment Response and Detect Acquired Resistance in Patients with Metastatic Melanoma,  Ramaciotti Foundation,  Grant,  2015 - 2018,  $99,911.
  • High-frequency ultrasound and photoacoustic imaging for Western Australia,  Australian Research Council,  Grant - Linkage (Infrastructure),  2018,  $631,198.
  • Liquid Biopsy for Prognosis of Uveal Melanoma,  The Ophthalmic Research Institute of Australia,  ORIA - Grant,  2018,  $27,551.
  • Understanding the Role of Melanoma Exosomes in Intercellular Communication,  Cancer Council of WA Inc,  Collaborative Cancer Grant Scheme,  2017 - 2018,  $43,230.
  • Translation of the HEROs Program of Multidisciplinary Therapy for Patients with Huntington s Disease (HD) into community settings,  Edith Cowan University,  ECU Industry Collaboration Scheme - 2016 Open Round,  2017 - 2018,  $169,003.
  • Blood based biomarkers predictive of treatment efficacy in metastatic melanoma,  Spinnaker Health Research Foundation,  Collaborative Research Partnership Grants,  2017 - 2018,  $107,448.
  • HEROs Huntington's disease Exercise Rehabilitation Optimisation Study,  Lotterywest,  Grant,  2014 - 2017,  $780,974.
  • Circulating Tumour Cells (CTCs) as biomarkers in metastatic melanoma,  Edith Cowan University,  ECU Early Career Researcher Grant - 2016,  2016 - 2017,  $30,000.
  • Medical and Health Research Infrastructure Fund (MHRIF) 2015 (Round 19),  Department of Health WA,  Medical and Health Research Infrastructure,  2016 - 2017,  $18,590.
  • Western Australia Single-Cell Isolation and Genomics Preparation Facility,  Australian Research Council,  Grant - Linkage (Infrastructure),  2017,  $430,000.
  • The effect of multidisciplinary therapy on neurodegeneration and clinical decline in Huntington’s disease individuals before the onset of diagnosable symptoms.,  Edith Cowan University,  ECU Early Career Researcher Grant - 2016,  2016 - 2017,  $27,900.
  • Gene expression profiling of circulating tumour cells (CTCs) isolated from metastatic melanoma patients using a microfluidic chip,  Cancer Council of WA Inc,  Grant - Early Career Investigator,  2016 - 2017,  $35,000.
  • Circulating Melanoma Cells as Predictive Biomarkers of Treatment Response and Disease Status,  Cancer Council of WA Inc,  Grant,  2015 - 2017,  $111,519.
  • A preliminary study investigating blood markers of response to treatment with immune system targeted therapy in advanced melanoma,  Cancer Council of WA Inc,  Grant - Early Career Investigator,  2015 - 2017,  $35,000.
  • Using a Functional Protein Array to Identify Autoantibody Biomarkers with Diagnostic Potential for Melanoma,  National Health and Medical Research Council,  Development Grants,  2014 - 2017,  $778,368.
  • Circulating Tumour Cells (CTCs) as a diagnostic tool to monitor disease progression in melanoma patients,  Edith Cowan University,  ECU Industry Collaboration Grant - 2015 (Round 1),  2015 - 2016,  $137,227.
  • Transcriptomic profiling of Circulating Tumour Cells (CTCs) isolated from metastatic melanoma patients,  Edith Cowan University,  School of Medical and Health Sciences Research Grant Scheme 2016,  2016,  $10,000.
  • Melanoma Mutation Profiling For Personalised Treatment,  National Health and Medical Research Council,  Project Grants,  2013 - 2016,  $765,359.
  • A Single-Molecule Super-Resolution Microscopy Facility in Western Australia,  Australian Research Council,  Grant - Linkage (Infrastructure),  2016,  $2,094,000.
  • PAX3 dysregulation in glioblastoma.,  Edith Cowan University,  ECU Early Career Researcher Grant - 2015,  2015 - 2016,  $22,800.
  • Mass Cytometry: A breakthrough in multidimensional systems biology,  Australian Research Council,  Grant - Linkage (Infrastructure),  2015 - 2016,  $1,081,489.
  • 2015 NHMRC Equipment Grant,  National Health and Medical Research Council,  Equipment Grant 2015,  2015 - 2016,  $6,798.
  • The role of DACH1 and the mir-200 family in medulloblastoma pathogenesis,  Cancer Council of WA Inc,  Cancer Council, Scholarship,  2014 - 2015,  $2,000.
  • In-Vivo Multispectral and X-Ray Micro-CT Imaging: Founding a Western Australian Small Animal Imaging Core Facility,  Australian Research Council,  Grant - Linkage (Infrastructure),  2010 - 2015,  $1,484,000.
  • 2014 NHMRC Equipment Grant Rob Newton and Mel Ziman,  National Health and Medical Research Council,  Equipment Grant 2014,  2014 - 2015,  $9,336.
  • Detection of Vemurafenib Resistance in Circulating Tumour Cells for Personalised Treatment of Melanoma,  Harry Perkins Institute of Medical Research,  Scott Kirkbride Melanoma Research Centre - Discovery Research Priming Grant,  2013 - 2014,  $68,182.
  • Standard Equipment Grant 2012,  National Health and Medical Research Council,  Equipment Grant 2012,  2012 - 2014,  $5,744.
  • PAX3-mediated melanocytic response to environmental factors,  Edith Cowan University,  ECU Early Career Researcher Grant - 2013,  2013 - 2014,  $25,000.
  • The Transcriptional profile of a metastatic circulation melanoma cell,  National Health and Medical Research Council,  Project Grants,  2011 - 2014,  $264,182.
  • Genetic Analysis of Melanoma Cells in Blood For Personalised Treatment Management,  Edith Cowan University,  ECU Early Career Researcher Grant - 2013,  2013 - 2014,  $24,083.
  • The role of DACH1 and the mir-200 family in medulloblastoma pathogenesis,  Telethon Kids Institute,  Honours Telethon Adventurers Children's Brain Cancer Training Award,  2014,  $4,000.
  • The effects of environmental enrichment on physiological markers of disease progression in patients with Huntington’s disease.,  Edith Cowan University,  ECU Early Career Researcher Grant - 2012 (Round 1),  2012 - 2013,  $24,568.
  • The Effects of Environmental Enrichment on Clinical Measures of Disease Progression and Quality of Life for Patients with Huntington's Disease,  Huntington's WA (Inc),  Lotterywest Grant,  2010 - 2013,  $530,317.
  • Detection of stem cell markers expression in circulating melanoma cells using multiparameter flow cytometry as a prognosis tool,  Edith Cowan University,  ECU Early Career Researcher Grant - 2012 (Round 1),  2012 - 2013,  $19,480.
  • Expanding Capacity and Capability in Western Australian Flow Cytometry for Earth, Oceans, Environmental and Biomedical Science: State-of-the-Art Four Laser and 12 Colour Analysis,  Australian Research Council,  Grant - Linkage (Infrastructure),  2012 - 2013,  $598,000.
  • Neon Transfection System and Biomedical Research Grade -30oC Freezer for Alzheimer’s and Melanoma Research,  National Health and Medical Research Council,  Equipment Grant 2011,  2011 - 2012,  $10,927.
  • The association between environmental stresses (UV, heat and chemicals) and melanoma incidence amongst staff at Telfer Gold Mine,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2011 - 2012,  $158,456.
  • Nano mechanical analysis of metastactic melanoma cancer cells using atomic force microscopy,  Cancer Council of WA Inc,  Cancer Council, Scholarship,  2012,  $7,500.
  • A high-throughput protein production and structure facility,  Australian Research Council,  Grant - Linkage (Infrastructure),  2012,  $470,000.
  • The Use of Circulating Melanoma Cells to monitor Treatment Efficacy in Patients with Cutaneous Malignant Melanoma,  University of Western Australia,  Grant - CaPCREU,  2010 - 2011,  $17,240.
  • Patient outcome affected by paramedic pre hospital treatment of patients with severe brain injuries,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2007 - 2011,  $174,837.
  • CCD Camera for Inverted Fluorescent Microscope in Alzheimer's and Melanoma Research,  National Health and Medical Research Council,  Equipment Grant,  2010 - 2011,  $10,881.
  • Evaluation of Paramedic Treatment Techniques to Assess Contributing Factors to Mortality in the Pre Hospital Management of Traumatic Brain Injury,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2009 - 2011,  $54,800.
  • Nature's Wonder,  Cocky Smart,  Grant,  2010 - 2011,  $125,023.
  • Neurological cell replacement therapies: improving outcomes by matching developmental profiles of transplanted cells with the damaged brain area. ,  Australian Research Council,  Grant - Discovery Projects,  2007 - 2010,  $118,176.
  • A Western Australian Core Cell Sorting Facility - Ultra-Small Objects and Rare Cell Populations,  Australian Research Council,  Grant - Linkage (Infrastructure),  2009 - 2010,  $524,000.
  • Detection and Characterisation of Circulating Cutaneous Malignant Melanoma Cells,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2009 - 2010,  $288,403.
  • Isolation and Characterisation of Melanoma Cancer Stem Cells,  Edith Cowan University,  ECU Early Career Researcher - Grant,  2008 - 2010,  $24,975.
  • Characterisation and Quantification of Circulating Melanoma Cells,  Cancer Council of WA Inc,  Cancer Council, Scholarship,  2010,  $3,000.
  • Quantification and Characterisation of Circulating Cutaneous Malignant Melanoma Cells,  Cancer Council of WA Inc,  Grant,  2009,  $70,000.
  • Detection of Migrating Melanoma Cells in Peripheral Blood of Patients with Metastatic Melanoma,  Cancer Council of WA Inc,  Grant,  2007 - 2008,  $2,000.
  • Developmental genes and Melanoma detection,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2005 - 2008,  $69,400.
  • A cryopreparation facility for Western Australia,  Australian Research Council,  Grant - Linkage (Infrastructure),  2008,  $485,000.
  • Development of a blood test for Cutaneous Malignant Melanoma,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2007 - 2008,  $115,019.
  • Development of a Blood Test for Cutaneous Malignant Melanoma,  Edith Cowan University Foundation,  Donation,  2007 - 2008,  $34,485.
  • Matching the developmental transcription factor profiles of transplanted cells and host injured brain regions is crucial for successful cell transplant therapies,  Harry Perkins Institute of Medical Research,  Grant,  2005 - 2006,  $60,000.
  • Corbett Research 'RotorGene' 2 channel real-time DNA multiplexing system,  Ramaciotti Foundation,  Grant,  2004 - 2005,  $49,000.

Recent Publications (within the last five years)

Book Chapters

  • Freeman, J., Gray, E., Ziman, M., (2015), Circulating Tumor Cells as Biomarkers in Cancer. Biomarkers in Cancer, 31-51, London, UK, Springer, DOI: 10.1007/978-94-007-7681-4_21.

Journal Articles

  • McEvoy, A., Wood, B., Ardakani, N., Pereira, M., Pearce, R., Cowell, L., Robinson, C., Grieu-Iacopetta, F., Spicer, A., Amanuel, B., Ziman, M., Gray, E., (2018), Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues. The Journal of Molecular Diagnostics, 20(2), 240-252, United States, Elsevier, DOI: 10.1016/j.jmoldx.2017.11.009.
  • Marsavela, G., Aya-Bonilla, C., Warkiani, M., Gray, E., Ziman, M., (2018), Melanoma circulating tumor cells: Benefits and challenges required for clinical application. Cancer Letters, 424(Jun 2018), 1-8, Ireland, Elsevier, DOI: 10.1016/j.canlet.2018.03.013.
  • Beasley, A., Isaacs, T., Khattak, M., Freeman, J., Allcock, R., Chen, F., Pereira, M., Yau, K., Bentel, J., Vermeulen, T., Calapre, L., Millward, M., Ziman, M., Gray, E., (2018), Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma. JCO Precision Oncology, epub ahead of print(May 17, 2017), 12p., United States, American Society of Clinical Oncology, DOI: 10.1200/PO.17.00279.
  • McEvoy, A., Warburton, L., Al-Ogaili, Z., Celliers, L., Calapre, L., Pereira, M., Khattak, M., Meniawy, T., Millward, M., Ziman, M., Gray, E., (2018), Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients. BMC Cancer, 18(1), Article no. 726, United Kingdom, BioMed Central Ltd, DOI: 10.1186/s12885-018-4637-6.
  • Cruickshank, T., Reyes, A., Penailillo, L., Pulverenti, T., Bartlett, D., Zaenker, P., Blazevich, T., Newton, R., Thompson, J., Lo, J., Ziman, M., (2018), Effects of multidisciplinary therapy on physical function in Huntington’s disease. Acta Neurologica Scandinavica, epub ahead of print(epub ahead of print), 1-8, United States, Wiley-Blackwell Publishing, Inc., DOI: 10.1111/ane.13002.
  • Zaenker, P., Lo, J., Pearce, R., Cantwell, P., Cowell, L., Lee, M., Quirk, C., Law, H., Gray, E., Ziman, M., (2018), A diagnostic autoantibody signature for primary cutaneous melanoma. Oncotarget, 9(55), 30539-30551, United States, Impact Journals LLC, DOI: 10.18632/oncotarget.25669.
  • Calapre, L., Warburton, L., Millward, M., Ziman, M., Gray, E., (2017), Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma. Cancer Letters, 404(28 Sept, 2017), 62-69, Shannon, Ireland, Elsevier, DOI: 10.1016/j.canlet.2017.06.030.
  • McEvoy, A., Calapre, L., Pereira, M., Giardina, T., Robinson, C., Khattak, M., Meniawy, T., Pritchard, A., Hayward, N., Amanuel, B., Millward, M., Ziman, M., Gray, E., (2017), Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma. Oncotarget, 8(45), 78890-78900, Albany, United States, Impact Journals LLC, DOI: 10.18632/oncotarget.20354.
  • Aya-Bonilla, C., Marsavela, G., Freeman, J., Lomma, C., Frank, M., Khattak, M., Tarek, M., Millward, M., Warkiani, M., Gray, E., Ziman, M., (2017), Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device. Oncotarget, 8(40), 67355-67368, New York, USA, Impact Journals LLC, DOI: 10.18632/oncotarget.18641.
  • Dejong, H., Abbott, S., Zelesco, M., Kennedy, B., Ziman, M., Wood, F., (2017), The validity and reliability of using ultrasound elastography to measure cutaneous stiffness, a systematic review. International Journal of Burns and Trauma, 7(7), 124-141, United States, E-Century Publications.
  • Calapre, L., Gray, E., Kurdykowski, S., David, A., Descargues, P., Ziman, M., (2017), SIRT1 activation mediates heat-induced survival of UVB damaged Keratinocytes. BMC Dermatology, 17(June 2017), Article No. 8, London, United Kingdom, BioMed Central, DOI: 10.1186/s12895-017-0060-y.
  • Phan, T., Carter, O., Adams, C., Waterer, G., Chung, L., Hawkins, M., Rudd, C., Ziman, M., Strobel, N., (2016), Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease. Chronic Respiratory Disease, 13(3), 220-228, London, UK, Sage Publications Ltd., DOI: 10.1177/1479972316634604.
  • Zaenker, P., Gray, E., Ziman, M., (2016), Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer Patients. Autoimmunity Reviews, 15(5), 477-483, Elsevier, DOI: 10.1016/j.autrev.2016.01.017.
  • Bartlett, D., Cruickshank, T., Hannan, A., Eastwood, P., Lazar, A., Ziman, M., (2016), Neuroendocrine and neurotrophic signaling in Huntington's Disease: Implications for pathogenic mechanisms and treatment strategies. Neuroscience and Biobehavioral Reviews, 71(2016), 444-454, Elsevier Ltd, DOI: 10.1016/j.neubiorev.2016.09.006.
  • Calapre, L., Gray, E., Kurdykowski, S., David, A., Hart, P., Descargues, P., Ziman, M., (2016), Heat-mediated reduction of apoptosis in UVB-damaged keratinocytes in vitro and in human skin ex vivo. BMC Dermatology, 16(1), Article no. 6, London, UK, BioMed Central Ltd., DOI: 10.1186/s12895-016-0043-4.
  • Reid, A., Freeman, J., Millward, M., Ziman, M., Gray, E., (2015), Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR. Clinical Biochemistry, 48(15), 999-1002, Philadelphia, USA, Elsevier, DOI: 10.1016/j.clinbiochem.2014.12.007.
  • Collins, L., Begeti, F., Panin, F., Lazar, A., Cruickshank, T., Ziman, M., Mason, S., Barker, R., (2015), Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington’s Disease. PLoS Currents, 7(Huntington Disease), online, San Francisco, USA, Public Library of Science, DOI: 10.1371/currents.hd.ded251617ae62a1364506b0521bd3761.
  • Gray, E., Rizos, H., Reid, A., Boyd, S., Pereira, M., Lo, J., Tembe, V., Freeman, J., Lee, J., Scolyer, R., Siew, K., Lomma, C., Cooper, A., Khattak, M., Meniawy, T., Long, G., Carlino, M., Millward, M., Ziman, M., (2015), Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma. Oncotarget, 6(39), 42008-42018, New York, USA, Impact Journals LLC, DOI: 10.18632/oncotarget.5788.
  • Bartlett, D., Boyle, GM., Ziman, M., Medic, S., (2015), Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells. PLoS One, 10(4), Article no. e0124154, San Francisco, USA, Public Library of Science, DOI: 10.1371/journal.pone.0124154.
  • Reyes, A., Cruickshank, T., Nosaka, K., Ziman, M., (2015), Respiratory muscle training on pulmonary and swallowing function in patients with Huntington's disease: A pilot randomised controlled trial. Clinical Rehabilitation, 29(10), 961-973, SAGE Publications Ltd, DOI: 10.1177/0269215514564087.
  • Cruickshank, T., Reyes, A., Ziman, M., (2015), A systematic review and meta-analysis of strength training in individuals with Multiple Sclerosis or Parkinson disease. Medicine, 94(4), e411, Wolters Kluwer Health, DOI: 10.1097/MD.0000000000000411.
  • Cruickshank, T., Thompson, J., Domínguez , J., Reyes, A., Bynevelt, M., Georgiou-Karistianis, N., Barker, R., Ziman, M., (2015), The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease: an exploratory study. Brain and Behavior, 5(2), 1-10, West Sussex, UK, John Wiley and Sons Ltd, DOI: 10.1002/brb3.312.
  • Gray, E., Reid, A., Bowyer, S., Calapre, L., Siew, K., Pearce, R., Cowell, L., Frank, M., Millward, M., Ziman, M., (2015), Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment. Journal of Investigative Dermatology, 135(8), 2040-2048, London, United Kingdom, Nature Publishing Group, DOI: 10.1038/jid.2015.127.
  • Blake, J., Ziman, M., (2014), Pax genes: regulators of lineage specification and progenitor cell maintenance. Development, 141(4), 737-751, United Kingdom, The Company of Biologists Ltd, DOI: 10.1242/dev.091785.
  • Fyfe, G., Fyfe, S., Meyer, J., Ziman, M., Sanders, K., Hill, J., (2014), Students reflecting on test performance and feedback: An on-line approach. Assessment and Evaluation in Higher Education, 39(2), 179-194, Routledge, DOI: 10.1080/02602938.2013.801063.
  • Cruickshank, T., Reyes, A., Penailillo, L., Thompson, J., Ziman, M., (2014), Factors that contribute to balance and mobility impairments in individuals with Huntington's disease. Basal Ganglia, 4(2), 67-70, Netherlands, Elsevier, DOI: 10.1016/j.baga.2014.04.002.
  • Klinac, D., Gray, E., Freeman, J., Reid, A., Bowyer, S., Millward, M., Ziman, M., (2014), Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma. BMC Cancer, 14(1), Article number 423, United Kingdom, BioMed Central Ltd, DOI: 10.1186/1471-2407-14-423.
  • Reyes, A., Cruickshank, T., Ziman, M., Nosaka, K., (2014), Pulmonary function in patients with Huntington's Disease. BMC Pulmonary Medicine, 14(2014), Article No. 89, BioMed Central Ltd, DOI: 10.1186/1471-2466-14-89.
  • Reyes, A., Cruickshank, T., Thompson, J., Ziman, M., Nosaka, K., (2014), Surface electromyography activity of submental muscles during swallowing and expiratory muscle training tasks of Huntington’s disease patients. Journal of Electromyography and Kinesiology, 24(1), 153-158, United Kingdom, Elsevier, DOI: 10.1016/j.jelekin.2013.09.009.
  • Blake, J., Ziman, M., (2013), The Characterisation of Pax3 Expressant Cells in Adult Peripheral Nerve. PLoS One, 8(3), e59184, USA, Public Library of Science, DOI: 10.1371/journal.pone.0059184.
  • Zaenker, P., Ziman, M., (2013), Serological Autoantibodies as Diagnostic Cancer Biomarkers - A Review. Cancer Epidemiology Biomarkers and Prevention, 22(12), 2161-81, USA, American Association for Cancer Research, DOI: 10.1158/1055-9965.EPI-13-0621.
  • Reid, A., Millward, M., Pearce, R., Lee, M., Frank, M., Ireland, A., Monshizadeh, L., Rai, T., Heenan, P., Medic, S., Kumarasinghe, P., Ziman, M., (2013), Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. British Journal of Dermatology, 168(1), 85-92, Wiley, DOI: 10.1111/bjd.12057.
  • Dye, DE., Medic, S., Ziman, M., Coombe, DR., (2013), Melanoma Biomolecules: Independently Identified but Functionally Intertwined. Frontiers in Oncology, 3 Sep(2013), Article No 252, Frontiers in Oncology online, Frontiers Research Foundation, DOI: 10.3389/fonc.2013.00252.
  • Reyes, A., Ziman, M., Nosaka, K., (2013), Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review. Chest, 143(5), 1386-1394, American College of Chest Physicians, DOI: 10.1378/chest.12-1442.
  • Calapre, L., Gray, E., Ziman, M., (2013), Heat stress: a risk factor for skin carcinogenesis. Cancer Letters, 337(1), 35-40, Ireland, Elsevier Ireland Ltd, DOI: 10.1016/j.canlet.2013.05.039.
  • Klinac, D., Gray, E., Milward, M., Ziman, M., (2013), Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. Frontiers in Oncology, 3(March 2013), Article 00054, DOI: 10.3389/fonc.2013.00054.
  • Thompson, J., Cruickshank, T., Penailillo, L., Lee, J., Newton, R., Barker, R., Ziman, M., (2013), The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington's disease: a pilot study. European Journal of Neurology, 20(9), 1325-1329, DOI: 10.1111/ene.12053.

Conference Publications

  • Maurya, D., Fooladvand, M., Gray, E., Ziman, M., Alameh, K., (2015), Lab-on-chip platform for circulating tumor cells isolation. Micro+Nano Materials, Devices, and Systems, 9668(6-9 Dec, 2015), 9668-34, Sydney, Australia, SPIE, DOI: 10.1117/12.2201127.

Research Student Supervision

Principal Supervisor

  • Doctor of Philosophy,  NEW PERSPECTIVES ON MELANOMA: THE ROLE OF PAX3
  • Master of Science (Human Biology),  PAX3 AND CUTANEOUS MALIGNANT MELANOMA
  • Master of Science (Human Biology),  THE EFFECTIVENESS OF AIRWAY MANAGEMENT IN THE PRE HOSPITAL TREATMENT OF TRAUMATIC BRAIN INJURY
  • Doctor of Philosophy,  THE IDENTIFICATION AND VALIDATION OF A DIAGNOSTIC SIGNATURE OF TUMOUR-ASSOCIATED AUTOANTIBODIES FOR THE EARLY DIAGNOSIS OF CUTANEOUS MELANOMA
  • Master of Science (Human Biology),  THE IDENTIFICATION OF DIAGNOSTIC SEROLOGICAL AUTOANTIBODIES FOR CUTANEOUS MELANOMA.
  • Doctor of Philosophy,  AN INVESTIGATION OF THE MECHANISM OF PAX7 MEDIATED ONCOGENESIS VIA IN SILICO BIOLOGY.
  • Doctor of Philosophy,  THE UTILITY OF MULTIDISCIPLINARY REHABILITATION AS A TREATMENT STRATEGY FOR CIRCADIAN RHYTHM AND SLEEP DISTURBANCES IN PREMANIFEST HUNTINGTON'S DISEASE
  • Master of Science (Human Biology),  PAX3 EXPRESSION, PROTEIN MODIFICATIONS AND DOWNSTREAM TARGET GENE PROFILING IN MELANOCYTES AND MELANOMA CELLS
  • Doctor of Philosophy,  THE ROLE OF PAX3/PAX7-FKHR IN MESENCHYMAL STEM CELL MYOGENIC DIFFERENTIATION AND RHABDOMYOSARCOMAGENESIS.
  • Doctor of Philosophy,  NEW PERSPECTIVES ON MELANOMA: THE ROLE OF PAX3
  • Master of Science (Human Biology),  PAX3 AND CUTANEOUS MALIGNANT MELANOMA
  • Doctor of Philosophy,  PULMONARY AND SWALLOWING FUNCTION IN PATIENTS WITH HUNTINGTON'S DISEASE.
  • Doctor of Philosophy,  THE CLINICAL UTILITY OF MULTIDISCIPLINARY REHABILITATION IN INDIVIDUALS WITH HUNTINGTON'S DISEASE
  • Doctor of Philosophy,  HEAT STRESS: A RISK FACTOR FOR SKIN CARCINOGENESIS
  • Master of Science (Human Biology),  MOLECULAR GENETIC INVESTIGATION OF AUTOSOMAL DOMINANT HEMIFACIAL MICROSOMIA.
  • Doctor of Philosophy,  THE DEVELOPMENTAL FUNCTION OF PAX 7: CHROMATIN-IMMUNOPRECIPITATION DISCOVERY OF PAX7 TARGET GENES
  • Master of Science (Human Biology),  THE EFFICACY OF INHALED METHOXYFLURANCE AND INTRANASAL FENTANYL FOR THE PRE HOSPITAL MANAGEMENT OF CARDIAC OR VISCERAL PAIN.
  • Doctor of Philosophy,  THE CHARACTERISATION OF PAX3 EXPRESSANT CELLS IN ADULT PERIPHERAL NERVE
  • Master of Science (Human Biology),  THE ROLE OF PAX3 IN THE METASTASIS OF CUTANEOUS MALIGNANT MELANOMA.
  • A POSSIBLE ROLE FOR PAX7 IN INITIATING DIFFERENTIATION OF NEURONAL CELLS IN THE OPTIC TECTUM DURING NORMAL DEVELOPMENT AND AFTER INJURY
  • Doctor of Philosophy,  CIRCULATING TUMOUR DNA: A NON-INVASIVE BIOMARKER FOR MELANOMA
  • Doctor of Philosophy,  BREATHING NEW LIFE: INVESTIGATING WAYS TO IMPROVE THE MENTAL HEALTH OF PEOPLE LIVING WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN WESTER AUSTRALIA
  • THE ROLE OF PAX3 AND PAX7 IN ALVEOLAR RHABDOMYOSARCOMA FOCUSING ON DNA BINDING DOMAINS, ALTERNATIVE SPLICING AND TARGET GENE ANALYSIS BY MICROARRAY
  • Master of Science (Human Biology),  OPTIMISATION OF THE ISOLATION AND IDENTIFICATION OF CIRCULATING MELANOMA CELLS
  • Doctor of Philosophy,  THE ROLE OF PAX7 IN THE FORMATION OF THE SUPERIOR COLLICULUS AND THE VERTEBRATE VISUAL SYSTEM.

Co-principal Supervisor

  • Master of Science (Human Biology),  THE EVALUATION OF MIDAZOLAM ON HEAD INJURED PATIENTS IN THE PREHOSPITAL SETTING
  • Master of Science (Human Biology),  GENETIC MARKERS IN CIRCULATING TUMOUR CELLS AS A MEASURE OF THE METASTATIC PROPENSITY OF UVEAL MELANOMA
Skip to top of page